In light of the strong desire to shorten timelines and lower cost for biologics such as monoclonals specially biosimilars, and address surging demand for complex proteins such as bispecific antibodies ...

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...

Key market opportunities in the biologics contract manufacturing sector include robust growth driven by rising demand due to ...

AGC Biologics to provide process development and GMP manufacturing for a novel therapy, leveraging its global microbial ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- C3 AI (NYSE: AI), the Enterprise AI application software company, today announced that Genentech, the medical biotechnology company, has selected C3 AI ...

The demands of developing new biologic modalities like bispecific antibodies are pushing the limits of traditional drug manufacturing. For the modern biomanufacturer, process intensification is ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Human cell and tissue products pass through either a ...

Good Manufacturing Practice (GMP) compliance in biologics contract manufacturing underpins product safety, efficacy, and regulatory approval. Service providers must integrate robust quality systems, ...

The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...

DUBLIN--(BUSINESS WIRE)--The "Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System ...

Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...

KOMO Biosciences today announced the appointment of Darryl Sampey, PhD, to its Scientific Advisory Board. Dr. Sampey brings more than two decades of experience in biologics development and ...